Showing results (11-20 of 106) with videos related to
Sort By:
Pageof 11
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Immune response by biological response modifiersM A Chirigos, E Schlick, W BudzynskiBiochemical and Biophysical Research Communications|January 13, 1998
1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cellsE Marcinkowska, A Wiedłocha, C RadzikowskiJournal of Immunogenetics|February 1, 1977
Molecular relationship between H-2 and ML antigens on leukaemia L-1210/v cellsL Strzadala, J Steuden, C RadzikowskiArchivum Immunologiae Et Therapiae Experimentalis|January 1, 1978
Studies on cell surface antigens of mouse leukemic and normal lymphocytes. II. Relationships between mammary leukemia, gross virus related and major histocompatibility antigens on L1210 leukemic lymphocytesJ Steuden, L Strzadała, C RadzikowskiArchivum Immunologiae Et Therapiae Experimentalis|January 1, 1985
LL2 cell line derived from transplantable murine Lewis lung carcinoma--maintenance in vitro and growth characteristicsD Duś, W Budzyński, C RadzikowskiArchivum Immunologiae Et Therapiae Experimentalis|January 1, 1989
Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. I. Acute toxicity and antitumor activity in mouse transplantable tumor systemsJ Matuszyk, H Kuśnierczyk, C RadzikowskiArchivum Immunologiae Et Therapiae Experimentalis|January 1, 1989
Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. II. Comparison of Now 85/34 and Novantrone (Lederle) acute toxicity and antitumor activityJ Matuszyk, H Kuśnierczyk, C RadzikowskiThe Journal of Steroid Biochemistry and Molecular Biology|October 21, 1998
Cell differentiating and anti-proliferative activity of side-chain modified analogues of 1,25-dihydroxyvitamin D3E Marcinkowska, A Kutner, C RadzikowskiArchivum Immunologiae Et Therapiae Experimentalis|January 1, 1989
Comparative evaluation of acute toxicity and antitumor activity of IF-XXV preparation and holoxanH Kuśnierczyk, J Matuszyk, C RadzikowskiIn Vivo (Athens, Greece)|May 1, 1990
Mouse L1210V leukemia as a model to analyse efficiency of leukemic cell elimination by immunotoxin, antibody and complement, and cytostatic agentsM Paprocka, A Wiedlocha, C RadzikowskiPageof 11